Table 2.
Comorbidity information for control and intervention groups. Presented as mean ± SD or N (%). Significance at p < 0.05.
| Control group (N = 10) | PMC group (N = 12) | p-value | |
|---|---|---|---|
| Comorbidities (mean ± SD) | 4.8 ±1.5 | 4.5 ±1.1 | 0.61a |
| OA | 2 (20) | 0 (0) | 0.07b |
| HF | 3 (20) | 4 (33) | 0.87b |
| Chronic lung disease | 3 (30) | 4 (33) | 0.87b |
| DM2 | 4 (40) | 2 (16.7) | 0.22b |
| Non-specific heart disease | 7 (70) | 5 (41.7) | 0.18b |
a
p-values represent independent sample t-test results.
b
p-values represent chi-square results.
PMC: progressive multicomponent intervention group; OA: osteoarthritis; HF: heart failure; DM2: type 2 diabetes mellitus.